Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

New Perspectives on Chronic Pain

neuroscienceCME Multimedia Snack

Premiere Date: Tuesday, December 11, 2012

This activity offers CE credit for:

1. Physicians (CME)
2. Pharmacists (ACPE)
3. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Wednesday, December 11, 2013
Note: Credit Is No Longer Available

Faculty

W. Vaughn McCall, MD, MS (Moderator) Case Distinguished University Chair Department of Psychiatry and Health Behavior Executive Vice Dean Medical College of Georgia Augusta University Augusta, GA

Daniel Clauw, MD  Professor of Anesthesiology, Medicine, and Psychiatry Director, Chronic Pain and Fatigue Research Center University of Michigan Ann Arbor, MI

Statement of Need

According to a recent Institute of Medicine report, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, pain is a significant public health problem that costs society at least $560 – $635 billion each year. This amount is equal to about $2,000 for each person living in the United States.(1)

While opioids remain a valid and effective analgesic strategy for patients suffering from a wide variety of painful conditions, they are not a panacea. Increasingly, physicians must balance patient expectations of adequate pain control with known limitations of opioid agents, including adverse effects, tolerance, addiction, withdrawal, and drug diversion. There is a variety of options, and knowing the mechanism of pain can inform and direct appropriate treatment.(2)

New approaches to the management of chronic pain require that clinicians understand and apply the new thinking about appropriate and timely treatment.(3) This neuroscienceCME Snack interview with pain expert Daniel Clauw, MD, will enlighten clinicians about the updated strategies for chronic pain.

---

1. Institute of Medicine [IOM]. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. 2011. IOM Website. http://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research.aspx. Published June 29, 2011. Accessed December 5, 2012.
2. Brush DE. Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia. J Med Toxicol. September 15, 2012. [Epub ahead of print]. PMID: 22983894.
3. Clauw D, McCarberg BH. Managing chronic pain with nonopioid analgesics: a multidisciplinary consult. Am J Med. 2012;125(5):S1. PMID: 22482859.

Activity Goal

Review and apply new approaches to chronic pain management in clinical practice.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Improve self-efficacy in the clinical management of chronic pain through an improved understanding of current prescribing protocols for opioid and non-opioid treatment.

Financial Support

This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Target Audience

Physicians, pharmacists, and other health care professionals whose scope of practice involves pain management.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs)
Universal Activity Number: 0376-0000-12-033-H01-P (recorded programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST730 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. McCall has nothing to disclose.

Dr. Clauw has disclosed that he receives grants/research support from Forest Laboratories, Inc.; and Pfizer Inc. He serves as a consultant to Cypress Biosciences, Inc.; Eli Lilly and Company; Forest Laboratories, Inc.; Jazz Pharmaceuticals, Inc.; Merck & Co., Inc.; Pfizer Inc.; Pierre Fabre Pharmaceuticals USA; and UCB, Inc.

Tony Graham, MD (peer review) has no disclosures to report.

Robert Kennedy (planning committee) has no disclosures to report.

Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.

Sandra Haas Binford, MAEd (planning committee) has no disclosures to report.

Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC, the faculty, and Lilly USA, LLC do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).